Diamond Biotechnology , Ltd Common Stock

As of the most recent data (June 2026), 6815.TWO shows a common stock of $400M. That compares with $340M in the prior-year period — up 17.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 6815.TWO's common stock is now $400M (was $340M) — a 17.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Diamond Biotechnology , Ltd is outperforming or lagging.

Tracking 6815.TWO's common stock over time shows whether Diamond Biotechnology , Ltd is scaling, shrinking, or reshaping that part of the business. The current reading is $400M That compares with $340M in the prior-year period — up 17.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Diamond Biotechnology , Ltd's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $400M) with ownership activity and broader fundamentals.